Masahiro Hasegawa Selected Research

Masahiro Hasegawa Research Topics

Disease

16	Rheumatoid Arthritis 09/2021 - 05/2007
14	Venous Thrombosis (Deep-Vein Thrombosis) 05/2018 - 10/2007
10	Osteoarthritis 08/2023 - 01/2008
7	Squamous Cell Carcinoma of Head and Neck 09/2014 - 07/2007
5	Infections 05/2023 - 01/2011
4	Pain (Aches) 01/2024 - 02/2013
4	Osteonecrosis (Kienbock's Disease) 09/2023 - 07/2008
4	Venous Thromboembolism 01/2021 - 05/2016
4	Knee Osteoarthritis 01/2021 - 10/2004
4	Hemorrhage 01/2020 - 09/2011
4	Neoplasms (Cancer) 11/2015 - 07/2007
3	Neuralgia (Stump Neuralgia) 01/2024 - 10/2019
3	Wounds and Injuries (Trauma) 07/2020 - 09/2011
3	Osteoporosis 01/2020 - 09/2014
2	Hip Osteoarthritis (Coxarthrosis) 01/2024 - 07/2008
2	Osteolysis 03/2023 - 09/2021
2	Synovitis 12/2021 - 01/2020
2	Rupture 03/2021 - 06/2018
2	Arthritis (Polyarthritis) 01/2019 - 11/2003
2	Necrosis 09/2018 - 08/2008
2	Joint Diseases (Joint Disease) 03/2018 - 04/2009
2	Inverted Papilloma 03/2016 - 09/2012
2	Hypersensitivity (Allergy) 01/2016 - 12/2010
2	Papillomavirus Infections 01/2015 - 07/2014
2	Pulmonary Embolism 05/2014 - 10/2011
2	Reperfusion Injury 03/2013 - 11/2012
2	Ischemia 03/2013 - 11/2012
2	Congenital Abnormalities (Deformity) 07/2012 - 08/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 08/2010 - 07/2007
2	Stress Fractures (Stress Fracture) 11/2008 - 07/2008
1	Chronic Pain 09/2022
1	Hip Dislocation 12/2021
1	Inflammation (Inflammations) 01/2020
1	Systemic Scleroderma (Systemic Sclerosis) 01/2019
1	Connective Tissue Diseases (Connective Tissue Disease) 07/2017
1	Fatigue 01/2017
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 01/2016
1	Retinoblastoma (Glioblastoma, Retinal) 01/2015
1	Oropharyngeal Neoplasms 09/2014
1	Vasculitis (Vasculitides) 05/2013

Drug/Important Bio-Agent (IBA)

7	Fondaparinux (Arixtra)FDA Link 01/2020 - 10/2010
6	MetalsIBA 09/2023 - 01/2007
6	TenascinIBA 01/2020 - 10/2004
5	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 08/2004
5	FibrinIBA 01/2018 - 06/2009
5	DNA (Deoxyribonucleic Acid)IBA 07/2014 - 11/2011
4	Biomarkers (Surrogate Marker)IBA 03/2018 - 01/2011
4	Infliximab (Remicade)FDA Link 03/2017 - 06/2010
4	Messenger RNA (mRNA)IBA 07/2014 - 09/2012
3	golimumab FDA Link 09/2021 - 03/2017
3	Polyethylene (Polythene)IBA 03/2021 - 08/2004
3	tocilizumab (atlizumab)FDA Link 01/2019 - 02/2012
3	fibrin fragment D (D-dimer)IBA 05/2018 - 06/2009
3	squamous cell carcinoma-related antigenIBA 03/2016 - 09/2012
3	Etanercept (Enbrel)FDA Link 02/2013 - 02/2012
3	Thrombin FDA Link 10/2011 - 02/2009
2	propylene diquat (PDQ(+))IBA 01/2024 - 01/2021
2	Durapatite (Hydroxylapatite)IBA 05/2023 - 09/2021
2	ultra-high molecular weight polyethylene (UHMWPE)IBA 03/2023 - 03/2021
2	Tumor Necrosis Factor InhibitorsIBA 09/2021 - 04/2017
2	edoxabanIBA 01/2021 - 01/2017
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2017 - 01/2008
2	AnticoagulantsIBA 05/2016 - 09/2011
2	Teriparatide (Parathar)FDA Link 01/2016 - 09/2014
2	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2015 - 07/2014
2	Hemostatics (Antihemorrhagics)IBA 10/2013 - 02/2012
2	Hemoglobins (Hemoglobin)IBA 10/2013 - 02/2012
2	OsteopontinIBA 01/2011 - 02/2009
1	Syndecan-4IBA 08/2023
1	zirconium oxide (zirconia)IBA 09/2021
1	Thromboplastin (Tissue Factor)IBA 01/2021
1	Protective AgentsIBA 07/2020
1	rebamipideIBA 07/2020
1	Denosumab FDA Link 01/2020
1	Fibrinogen (Factor I)FDA Link 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ElastinIBA 06/2018
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 07/2017
1	Cell Cycle ProteinsIBA 01/2015
1	platelet membrane glycoprotein VIIBA 11/2014
1	Indicators and Reagents (Reagents)IBA 09/2014
1	EdaravoneIBA 03/2013
1	Free RadicalsIBA 03/2013

Therapy/Procedure

23	Knee Replacement Arthroplasty (Total Knee Replacement) 03/2023 - 06/2002
14	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2024 - 10/2010
7	Arthroplasty 09/2023 - 04/2009
7	Orthopedic Procedures 01/2021 - 02/2012
5	Therapeutics 04/2017 - 10/2009
4	Prostheses and Implants (Prosthesis) 05/2012 - 12/2006
3	Intra-Articular Injections 12/2021 - 01/2018
3	Reoperation 11/2015 - 10/2009
2	Tourniquets 03/2013 - 10/2007
2	Conservative Treatment 09/2011 - 08/2008
1	Debridement 05/2023
1	Neck Dissection (Radical Neck Dissection) 09/2014
1	Chemoradiotherapy 09/2014
1	Perioperative Period 05/2014
1	Chemoprevention 05/2014
1	Compression Stockings 05/2014
1	Intraperitoneal Injections 03/2013